- Home
- RPID vs ALEC Comparison
RPID vs ALEC Comparison
Compare RPID & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPID
- ALEC
- Stock Information
- Founded
- RPID 2006
- ALEC 2013
- Country
- RPID United States
- ALEC United States
- Employees
- RPID N/A
- ALEC N/A
- Industry
- RPID Medical Specialities
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RPID Health Care
- ALEC Health Care
- Exchange
- RPID Nasdaq
- ALEC Nasdaq
- Market Cap
- RPID 154.7M
- ALEC 124.0M
- IPO Year
- RPID 2021
- ALEC 2019
- Fundamental
- Price
- RPID $3.09
- ALEC $1.25
- Analyst Decision
- RPID Strong Buy
- ALEC Hold
- Analyst Count
- RPID 2
- ALEC 9
- Target Price
- RPID $8.00
- ALEC $3.40
- AVG Volume (30 Days)
- RPID 82.9K
- ALEC 5.3M
- Earning Date
- RPID 11-07-2025
- ALEC 11-06-2025
- Dividend Yield
- RPID N/A
- ALEC N/A
- EPS Growth
- RPID N/A
- ALEC N/A
- EPS
- RPID N/A
- ALEC N/A
- Revenue
- RPID $30,289,000.00
- ALEC $81,130,000.00
- Revenue This Year
- RPID $16.63
- ALEC N/A
- Revenue Next Year
- RPID $21.98
- ALEC $290.64
- P/E Ratio
- RPID N/A
- ALEC N/A
- Revenue Growth
- RPID 22.57
- ALEC 46.77
- 52 Week Low
- RPID $0.87
- ALEC $0.87
- 52 Week High
- RPID $4.50
- ALEC $6.14
- Technical
- Relative Strength Index (RSI)
- RPID 52.91
- ALEC 25.65
- Support Level
- RPID $2.65
- ALEC $1.45
- Resistance Level
- RPID $3.13
- ALEC $1.34
- Average True Range (ATR)
- RPID 0.20
- ALEC 0.15
- MACD
- RPID 0.00
- ALEC -0.06
- Stochastic Oscillator
- RPID 84.40
- ALEC 3.57
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.